Multicenter Study to Assess the Efficacy and Safety of Methyl Aminolevulinate Hydrochloride (MAL) 16.8% Cream (CD06809-41) Versus Vehicle Cream for Actinic Keratosis of the Face

NCT04085367 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

557

Enrollment

INDUSTRY

Sponsor class

Conditions

Actinic Keratoses

Interventions

DRUG: MAL 16.8% cream
DRUG: MAL Vehicle Cream

Sponsor

Galderma R&D